Le Lézard
Classified in: Health
Subjects: HEALTH, Philanthropy

Canadians Come Together to Make Positive Impact During Multiple Sclerosis Awareness Month This May


TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- May is Multiple Sclerosis (MS) Awareness Month and MS Canada invites Canadians to join the MS community and navigate MS together. At MS Canada, we work to educate people on the impact of MS in our country and support people living with MS through funding research, driving advocacy, and providing support programs. MS Awareness Month is an opportunity to raise awareness and funds to support the over 90,000 Canadians living with the neurological disease. This May we ask Canadians to come together and raise awareness, celebrate the MS community, and have a meaningful impact across Canada.

MS Awareness Month Moments

"MS Awareness Month is defined by active and meaningful participation. This May, we invite everyone to help us bring attention to the prevalence of the disease and need for support. There are many ways to join the MS community, you can volunteer with MS Canada, share accurate MS information on social media, or participate in the May 50K or MS Walk." said Dr. Pamela Valentine, President and CEO, MS Canada. "MS Walk brings the MS community and their network, including caregivers, friends and family, all together for one day of collective action, moving us one step closer to a world free of MS."

"As someone who was diagnosed with multiple sclerosis in 2020, I am no stranger to how overwhelming an MS journey can feel, " said Karen Jacoby, MS Canada Ambassador. "I volunteer during MS Awareness Month because I am driven by hope?and I encourage everyone to consider supporting the community, as I know firsthand the power that having other people demonstrating public support has had on my MS journey."

This May, join the MS community as we navigate MS together, raising awareness on the complexities and realities that MS brings to the person living with it as well as their friends and family. Join us in advocating on behalf of the MS community to have equal access to care, prioritize MS research exploring pathways to cures, and access to social programs that improve quality of life.

For more information about MS Awareness Month, including how you can get involved, please visit mscanada.ca/msawarnessmonth.

About MS Canada
At MS Canada, we are inspired by the vision of a world free of multiple sclerosis. We focus on support, advocacy and research that will positively impact the lives of people living with, and affected by MS. For over 75 years, we have been a trusted connection for the MS community to valuable resources and programs needed on their unique MS journey. We advocate for improved policies and systems that will better support Canadians living with MS. We invest in life-changing research that will advance treatment and care, enhance well-being, help to understand, and halt disease progression, and ultimately prevent MS.
For more information visit mscanada.ca

About multiple sclerosis (MS)
Canada has one of the highest rates of multiple sclerosis (MS) in the world. On average, 12 Canadians are diagnosed every day. MS is a neurological disease of the central nervous system (brain, spinal cord). Most people are diagnosed with MS between the ages of 20 and 49. It is considered an episodic disability meaning that the severity and duration of episodes of illness and disability can vary, often followed by periods of wellness. It can also be progressive.

Media Contact
Laila Namur
Manager, Corporate Communications
MS Canada
778 874 4876
[email protected]



These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: